{
    "clinical_study": {
        "@rank": "21606", 
        "arm_group": {
            "arm_group_label": "CCM aggregate", 
            "arm_group_type": "Experimental", 
            "description": "Taking of 10 blood samples"
        }, 
        "brief_summary": {
            "textblock": "Electric stimulation by cardial contractility modulation (CCM)to improve contractility and\n      physical capacity"
        }, 
        "brief_title": "Acute Neurotrophic Effects of a Non Excitatory Cardial Stimulation by Optimizier III System in Patients With Heart Failure", 
        "condition": "CCM Implantation", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  planned CCM Implantation\n\n          -  systolic left ventricular dysfunction despite of adequate therapy of heart failure\n             (NYHA II, III, IV)\n\n          -  implanted pacemaker, defibrillatoror or pacemaker  during CS intubation\n\n          -  written informed consent\n\n          -  open entryways\n\n        Exclusion Criteria:\n\n          -  anemia HB<8 mg/dl\n\n          -  lying CS tube or CS being not able to intubate\n\n          -  chronic atrial fibrillation or flutter\n\n          -  mechanic tricuspid valve prothesis\n\n          -  no acces via subclavian vein\n\n          -  patients with VVI pacemaker being stimulated 110%\n\n          -  idiopathic hypertrophic cardiomyopathy, restrictiv constrictiv cardiomyopathy or\n             heart failure because of known inflammatory or infiltrative illnesses or constrictive\n             illness\n\n          -  acute myocardial ischemia presented by angina pectoris or ECG changes under load\n\n          -  patients being hospitalized because of heart failure during the last month and have\n             to be treated with intravenous diuretics or inotropic subtances\n\n          -  acute coronary syndrome should not be implanted for at least 3 month\n\n          -  patients with mechanic aortic or tricuspid valve\n\n          -  patients after heart transplantation\n\n          -  patients with clinical significant ectopy, defined by > 8.900 PVCs during 24 hours at\n             beginning Holter monitoring\n\n          -  patients after hyperttensive crisis\n\n          -  patients with acute renal failure\n\n          -  EF > 35\n\n          -  patients after left ventricular pacemaker electrode\n\n          -  pregnant or breast feeding women\n\n          -  patients with heart failure after sepsis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789112", 
            "org_study_id": "12-032"
        }, 
        "intervention": {
            "arm_group_label": "CCM aggregate", 
            "description": "Taking of blood sample", 
            "intervention_name": "Blood sample", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 8, 2013", 
        "location": {
            "contact": {
                "email": "pschauerte@ukaachen.de", 
                "last_name": "Patrick Schauerte, Prof. Dr. med., MD", 
                "phone": "+49 241 80 89669"
            }, 
            "facility": {
                "address": {
                    "city": "Aachen", 
                    "country": "Germany", 
                    "state": "North Rhine Westfalia", 
                    "zip": "52074"
                }, 
                "name": "Univeristy Hospital Aachen"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "Acute Neurotrophic Effects of a Non Excitatory Cardial Stimulation by Optimizier III System in Patients With Heart Failure", 
        "overall_contact": {
            "email": "pschauerte@ukaachen.de", 
            "last_name": "Patrick Schauerte, Prof. Dr. med., MD", 
            "phone": "+49 241 80 89301"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "positive inotropic effects by CCM stimulation", 
            "safety_issue": "No", 
            "time_frame": "15 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789112"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "RWTH Aachen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "RWTH Aachen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}